Upcoming changes to the program

The Australian Government has now accepted the evidence based recommendations of the Medical Services Advisory Committee (MSAC) that a primary human papillomavirus (HP) test should replace the current Pap test for cervical screening. This will ensure Australian women will have access to a cervical screening program that is safe, effective, efficient and based on current evidence.

The renewed National Cervical Screening Program will commence on 1 May 2017 when the HPV screening test will become available on the Medicare Benefits Schedule and the National Cancer Screening Register will be in place to support the renewed clinical pathway.

More information is available on the Future changes to cervical screening page.

Until may 2017, do not delay your 2 yearly Pap test. Cervical cancer is one of the most preventable cancers.

Public Consultation: new Clinical Management Guidelines

The draft Clinical Management Guidelines for the Prevention of Cervical Cancer is available for public consultation from 15 February to 15 March 2016.

This is an opportunity for all stakeholders to provide their feedback into these independently developed Guidelines by Cancer Council Australia.

Feedback can be provided through the Public Consultation Cancer Guidelines Wiki platform.